Detalles de la búsqueda
1.
Osimertinib after Chemoradiotherapy in Stage III EGFR-Mutated NSCLC.
N Engl J Med
; 2024 Jun 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-38828946
2.
KEYNOTE-033: Randomized phase 3 study of pembrolizumab vs docetaxel in previously treated, PD-L1-positive, advanced NSCLC.
Int J Cancer
; 153(3): 623-634, 2023 Aug 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-37141294
3.
A new era of the Asian clinical research network: a report from the ATLAS international symposium.
Jpn J Clin Oncol
; 53(7): 619-628, 2023 Jun 29.
Artículo
en Inglés
| MEDLINE | ID: mdl-37099440
4.
Cemiplimab monotherapy for first-line treatment of advanced non-small-cell lung cancer with PD-L1 of at least 50%: a multicentre, open-label, global, phase 3, randomised, controlled trial.
Lancet
; 397(10274): 592-604, 2021 02 13.
Artículo
en Inglés
| MEDLINE | ID: mdl-33581821
5.
The treatment landscape of advanced angiosarcoma in Asia-A multi-national collaboration from the Asian Sarcoma Consortium.
Cancer Sci
; 112(3): 1095-1104, 2021 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-33393133
6.
Final overall survival analysis of the phase 3 HERITAGE study demonstrates equivalence of trastuzumab-dkst to trastuzumab in HER2-positive metastatic breast cancer.
Breast Cancer Res Treat
; 188(2): 369-377, 2021 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-34125340
7.
Patterns and outcomes of immune-related adverse events in solid tumor patients treated with immune checkpoint inhibitors in Thailand: a multicenter analysis.
BMC Cancer
; 21(1): 1275, 2021 Nov 25.
Artículo
en Inglés
| MEDLINE | ID: mdl-34823493
8.
Experience from Asian centers in a named-patient-use program for afatinib in patients with advanced non-small-cell lung cancer who had progressed following prior therapies, including patients with uncommon EGFR mutations.
Int J Clin Oncol
; 26(5): 841-850, 2021 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-33783657
9.
The efficacy and safety of the addition of olanzapine to ondansetron and dexamethasone for prevention of chemotherapy-induced nausea and vomiting in patients receiving highly emetogenic chemotherapy.
Int J Clin Oncol
; 25(2): 396-402, 2020 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-31776732
10.
Incidence of infusion hypersensitivity reaction after withholding dexamethasone premedication in early breast cancer patients not experiencing two previous cycles of infusion hypersensitivity reaction for weekly paclitaxel chemotherapy.
Support Care Cancer
; 26(7): 2471-2477, 2018 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-29435713
11.
A Difference in the Incidences of Hypersensitivity Reactions to Original and Generic Taxanes.
Chemotherapy
; 62(2): 134-139, 2017.
Artículo
en Inglés
| MEDLINE | ID: mdl-27997900
12.
Effect of a Proposed Trastuzumab Biosimilar Compared With Trastuzumab on Overall Response Rate in Patients With ERBB2 (HER2)-Positive Metastatic Breast Cancer: A Randomized Clinical Trial.
JAMA
; 317(1): 37-47, 2017 01 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-27918780
13.
SHP-1 promoter 2 methylation in cerebrospinal fluid for diagnosis of leptomeningeal epithelial-derived malignancy (carcinomatous meningitis).
J Neurooncol
; 129(3): 395-403, 2016 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-27401153
14.
The role of SHP-1 promoter 2 hypermethylation detection of lymph node micrometastasis in resectable stage I non-small cell lung cancer as a prognostic marker of disease recurrence.
Int J Clin Oncol
; 19(4): 586-92, 2014 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-23824557
15.
Intercalated combination of chemotherapy and erlotinib for patients with advanced stage non-small-cell lung cancer (FASTACT-2): a randomised, double-blind trial.
Lancet Oncol
; 14(8): 777-86, 2013 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-23782814
16.
Impact of LKB1 status on radiation outcome in patients with stage III non-small-cell lung cancer.
Sci Rep
; 14(1): 6146, 2024 03 14.
Artículo
en Inglés
| MEDLINE | ID: mdl-38480816
17.
Development of Clinical Prediction Score for Chemotherapy Response in Advanced Non-Small Cell Lung Cancer Patients.
Healthcare (Basel)
; 11(3)2023 Jan 18.
Artículo
en Inglés
| MEDLINE | ID: mdl-36766868
18.
Safety Following COVID-19 Booster Vaccine with BNT162b2 Compared to mRNA-1273 in Solid Cancer Patients Previously Vaccinated with ChAdOx1 or CoronaVac.
Vaccines (Basel)
; 11(2)2023 Feb 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-36851234
19.
Efficacy and Safety of Ceritinib 450 mg/day with Food and 750 mg/day in Fasted State in Treatment-Naïve Patients with ALK+ Non-Small Cell Lung Cancer: Results from the ASCEND-8 Asian Subgroup Analysis.
Cancer Res Treat
; 55(1): 83-93, 2023 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-35344649
20.
EUS-guided radiofrequency ablation plus chemotherapy versus chemotherapy alone for pancreatic cancer (ERAP): An observational open-label pilot study.
Endosc Ultrasound
; 12(5): 402-408, 2023.
Artículo
en Inglés
| MEDLINE | ID: mdl-37969163